First launched as the Angioplasty Summit by Dr. Seung-Jung Park in 1995, TCTAP has evolved into the premier international conference in interventional cardiovascular medicine in the Asia-Pacific region. With dynamic academic exchanges and collaborations across cardiology, thoracic surgery, radiology, vascular surgery, pediatric cardiology, and cardiac rehabilitation, TCTAP continues to play a pivotal role in advancing cardiovascular care worldwide.
Bringing together the latest knowledge and innovations from East and West, TCTAP serves as a global platform for sharing expertise, fostering collaboration, and driving continuous improvement in the treatment of cardiovascular disease.
Held annually in late April in Korea, TCTAP offers a comprehensive program encompassing the latest basic and clinical research, state-of-the-art interventional techniques, and emerging device technologies. The conference also features expert-led debates on evolving strategies, as well as discussions on pharmacologic therapies and multidisciplinary approaches, providing invaluable insights for the optimal management of coronary and structural heart disease.
Who Attends TCTAP
- Interventional cardiologists
- General cardiologists
- Physicians interested in cardiology and vascular medicine
- Radiologists
- Basic scientists
- Vascular medicine specialists
- Vascular surgeons
- Cardiac surgeons
- Interventional pediatricians
- Nurses and technologists
- Other healthcare professionals with a special interest in interventional vascular therapy and medicine
Who Supports TCTAP
TCTAP is organized by the CardioVascular Research Foundation (CVRF) and partially funded by educational grants from commercial supporters. We extend our special appreciation to Asan Medical Center, Seoul, Korea and the Clinical Research Centers for Ischemic Heart Disease for their continued support of our program.
Upcoming Events
-
31st TCTAP 2026
April 29 - May 2, 2026 | Coex, Seoul, Korea -
32nd TCTAP 2027
April 28 - May 1, 2027 | Coex, Seoul, Korea